TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (OTCBB: OGEN) (the “Company”) announced today that its common stock has been approved for listing on the NYSE Euronext’s NYSE MKT. Trading is expected to commence on the NYSE MKT on Wednesday, April 10, 2013 under the ticker symbol ‘OGEN’. “We are pleased to begin trading on NYSE MKT,” said John N. Bonfiglio PhD, President and CEO of Oragenics. “This listing marks an important step in our Company’s development by giving us greater access to a broader investor base and by providing increased transparency and liquidity for the financial community.”
